1. Show article details.

    Koffey's Politan takes 9% stake in Masimo, to push for change

    Reuters – 5:31 PM ET 08/16/2022

    Activist investor Politan Capital Management on Tuesday said it owns a nearly 9% stake in Masimo Corp (MASI) and plans to push the medical device maker to make changes, sending the company's share price up 6%. Politan, founded by veteran investor Quentin Koffey, said in a regulatory filing it believes the company's stock price is undervalued.

  2. Show article details.

    Centene Subsidiary Selected to Continue Serving Mississippi's Medicaid Managed Care Members

    PR Newswire – 2:32 PM ET 08/10/2022

    ST. LOUIS, Aug. 10, 2022 Centene Corporation (CNC) announced today its Mississippi subsidiary, Magnolia Health Plan, has been awarded the Mississippi Division of Medicaid contract. "We are honored to have the opportunity to continue serving our state partners to help build a healthier Mississippi," said Brent Layton, Centene's President and Chief Operating Officer.

  3. Show article details.

    'I Think It's Too Cheap To Get Rid Of': Jim Cramer Recommends Holding Onto This Stock

    Benzinga – 8:16 AM ET 08/03/2022

    On CNBC's "Mad Money Lightning Round," Jim Cramer said Lions Gate Entertainment Corp is a "value trap." He added, "While it makes money, it's not what this market wants." When asked about Radware Ltd , Cramer said, "I think it's too cheap to get rid of. Cramer said Centene Corp is "doing very, very well." He recommended holding onto the stock.

  4. Show article details.

    BRIEF-Centene Files Preliminary Proxy Statement For Special Meeting To Propose Enhanced Corporate Governance Provisions

    Reuters – 5:38 PM ET 08/01/2022

    Centene Corp (CNC): * CENTENE FILES PRELIMINARY PROXY STATEMENT FOR SPECIAL MEETING TO PROPOSE ENHANCED CORPORATE GOVERNANCE PROVISIONS. * Centene Corp (CNC) - JAMES DALLAS, CHAIRMAN OF BOARD, HAS INFORMED BOARD THAT HE WILL STEP DOWN AS CHAIRMAN OF BOARD BY 2023 ANNUAL MEETING OF STOCKHOLDERS.

  5. Show article details.

    CENTENE FILES PRELIMINARY PROXY STATEMENT FOR SPECIAL MEETING TO PROPOSE ENHANCED CORPORATE GOVERNANCE PROVISIONS

    PR Newswire – 4:35 PM ET 08/01/2022

    ST. LOUIS, Aug. 1, 2022 Centene Corporation (CNC) announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission in connection with a special stockholders meeting to approve amendments to Centene's Amended and Restated Certificate of Incorporation to enhance the Company's corporate governance.

  6. Show article details.

    Health Net Providing Special Assistance to Members Affected by Wildfires

    PR Newswire – 4:00 PM ET 08/01/2022

    Health Net Assisting Members in Siskiyou County During State of Emergency. SACRAMENTO, Calif. Health Net members can also call MHN for coping support. If members cannot reach their primary care provider during a declared state of emergency, Health Net provides access to telehealth services at no cost.

  7. Show article details.

    Looking Into Centene's Recent Short Interest

    Benzinga – 2:21 PM ET 08/01/2022

    Centene's short percent of float has fallen 14.67% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.

  8. Show article details.

    Here's How Much $1000 Invested In Centene 15 Years Ago Would Be Worth Today

    Benzinga – 3:02 PM ET 07/28/2022

    Centene has outperformed the market over the past 15 years by 13.95% on an annualized basis producing an average annual return of 21.12%. Currently, Centene has a market capitalization of $53.80 billion. Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 15 years ago, it would be worth $17,166.13 today based on a price of $92.74 for CNC at the time of writing.

  9. Show article details.

    Centene's Return On Capital Employed Overview

    Benzinga – 10:56 AM ET 07/27/2022

    Benzinga Pro data, Centene reported Q2 sales of $35.94 billion. Earnings data without context is not clear and can be difficult to base trading decisions on. It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies.

  10. Show article details.

    Health Net Providing Special Assistance to Members Affected by Wildfires

    PR Newswire – 11:00 AM ET 07/26/2022

    Health Net Assisting Members in Mariposa County During State of Emergency. SACRAMENTO, Calif. Health Net members can also call MHN for coping support. If members cannot reach their primary care provider during a declared state of emergency, Health Net provides access to telehealth services at no cost.

  11. Show article details.

    Centene Says Q2 In Line With Expectations Outlined During June Investor Day, Ups FY22 Guidance

    Benzinga – 8:05 AM ET 07/26/2022

    Centene Says Q2 In Line With Expectations Outlined During June Investor Day, Ups FY22 Guidance

  12. Show article details.

    Centene: Q2 Earnings Insights

    Benzinga – 7:28 AM ET 07/26/2022

      Centene reported its Q2 earnings results on Tuesday, July 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Centene beat estimated earnings by 11.32%, reporting an EPS of $1.77 versus an estimate of $1.59. Revenue was up $4.91 billion from the same period last year.

  13. Show article details.

    Earnings Scheduled For July 26, 2022

    Benzinga – 6:12 AM ET 07/26/2022

      ** General Motors is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion. ** Pentair is projected to report quarterly earnings at $1.00 per share on revenue of $1.05 billion. ** IVERIC bio is expected to report earnings for its second quarter. ** NexPoint Residential is estimated to report quarterly loss at $0.24 per share on revenue of $63.85 million.

  14. Show article details.

    BRIEF-Centene Posts Q2 Loss Per Share Of $0.29

    Reuters – 6:08 AM ET 07/26/2022

    Centene Corp (CNC): * ORATION REPORTS SECOND QUARTER 2022 RESULTS. * QTRLY DILUTED LOSS PER SHARE OF $ * INCREASED 2022 FULL-YEAR ADJUSTED DILUTED EPS GUIDANCE BY ANOTHER $0.05. * QTRLY ADJUSTED DILUTED EPS OF $1.77. * FOR THE SECOND QUARTER OF 2022, TOTAL REVENUES INCREASED 16% TO $35.9 BILLION FROM $31.0 BILLION IN COMPARABLE PERIOD OF 2021.

  15. Show article details.

    CENTENE CORPORATION REPORTS SECOND QUARTER 2022 RESULTS

    PR Newswire – 6:00 AM ET 07/26/2022

    -- Diluted Loss Per Share of $, including real estate charge; Adjusted Diluted EPS of $1.77 -- ST. LOUIS, July 26, 2022 /PRNewswire/ -- Centene Corporation (CNC) announced today its financial results for the second quarter ended June 30, 2022. In summary, the 2022 second quarter results were as follows: "Our strong second quarter results reflect the consistency of Centene's (CNC) product performance.

  16. Show article details.

    BRIEF-Centene Signs Deal To Divest Spanish And Central European Businesses

    Reuters – 7:17 AM ET 07/25/2022

    Centene Corp (CNC): * CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST ITS SPANISH AND CENTRAL EUROPEAN BUSINESSES. * Centene Corp (CNC) - CENTENE TO SELL ITS CONTINENTAL EUROPEAN BUSINESSES TO VIVALTO SANTÉ. * Centene Corp (CNC) - CENTENE INTENDS TO USE MAJORITY OF NET PROCEEDS FROM SALE TO REPURCHASE STOCK AND BALANCE TO REDUCE DEBT.

  17. Show article details.

    Centene to sell some Europe-based hospital businesses to Vivalto Santé

    Reuters – 7:10 AM ET 07/25/2022

    Health insurer Centene Corp (CNC) said on Monday it has agreed to sell its Spanish and Central European businesses to private hospital company Vivalto Santé. Financial details of the deal were not disclosed.

  18. Show article details.

    CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST ITS SPANISH AND CENTRAL EUROPEAN BUSINESSES

    PR Newswire – 7:00 AM ET 07/25/2022

    Centene to sell its continental European businesses to Vivalto Santé . Another milestone in Centene's (CNC) value creation program and ongoing portfolio review ST. LOUIS, July 25, 2022 /PRNewswire/ -- Centene Corporation (CNC) announced today that as part of its previously announced review of strategic alternatives for its international portfolio, it has signed a definitive agreement to sell to Vivalto Sa...

  19. Show article details.

    More California Families Can Eat Healthy with Health Net's $120,000 Grant to Support Vouchers 4 Veggies Program

    PR Newswire – 11:00 AM ET 07/19/2022

    Community-based organizations, El Concilio and E Center, partner to provide residents of San Joaquin, Sutter and Yuba counties with fresh fruits and vegetables. SACRAMENTO, Calif. About Health Net:Founded in California more than 40 years ago, Health Net believes every person deserves a safety net for their health, regardless of age, income, employment status or current state of health.

  20. Show article details.

    Peering Into Centene's Recent Short Interest

    Benzinga – 10:16 AM ET 07/15/2022

    Centene's short percent of float has fallen 27.54% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.

Page:

Today's and Upcoming Events

  • Oct
    24

    CNC to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Jul
    26

    CNC announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.